287 related articles for article (PubMed ID: 25686834)
1. miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway.
Xu X; Chen W; Miao R; Zhou Y; Wang Z; Zhang L; Wan Y; Dong Y; Qu K; Liu C
Oncotarget; 2015 Feb; 6(6):3988-4004. PubMed ID: 25686834
[TBL] [Abstract][Full Text] [Related]
2. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.
Zhang B; Zhang Y; Zou X; Chan AW; Zhang R; Lee TK; Liu H; Lau EY; Ho NP; Lai PB; Cheung YS; To KF; Wong HK; Choy KW; Keng VW; Chow LM; Chan KK; Cheng AS; Ko BC
J Pathol; 2017 Dec; 243(4):418-430. PubMed ID: 28862757
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
Huang X; Qin J; Lu S
Int J Clin Exp Pathol; 2015; 8(2):1515-24. PubMed ID: 25973036
[TBL] [Abstract][Full Text] [Related]
4. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.
Christoffersen NR; Shalgi R; Frankel LB; Leucci E; Lees M; Klausen M; Pilpel Y; Nielsen FC; Oren M; Lund AH
Cell Death Differ; 2010 Feb; 17(2):236-45. PubMed ID: 19696787
[TBL] [Abstract][Full Text] [Related]
5. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
[TBL] [Abstract][Full Text] [Related]
6. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
7. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
[TBL] [Abstract][Full Text] [Related]
8. Effect of Tumor Suppressor MiR-34a Loaded on ZSM-5 Nanozeolite in Hepatocellular Carcinoma: In Vitro and In Vivo Approach.
Salah Z; Abd El Azeem EM; Youssef HF; Gamal-Eldeen AM; Farrag AR; El-Meliegy E; Soliman B; Elhefnawi M
Curr Gene Ther; 2019; 19(5):342-354. PubMed ID: 31701846
[TBL] [Abstract][Full Text] [Related]
9. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of transcription factor FoxM1 by p53 enhances oxaliplatin-induced senescence in hepatocellular carcinoma.
Qu K; Xu X; Liu C; Wu Q; Wei J; Meng F; Zhou L; Wang Z; Lei L; Liu P
Cancer Lett; 2013 Apr; 331(1):105-14. PubMed ID: 23262037
[TBL] [Abstract][Full Text] [Related]
11. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
Yang F; Li QJ; Gong ZB; Zhou L; You N; Wang S; Li XL; Li JJ; An JZ; Wang DS; He Y; Dou KF
Technol Cancer Res Treat; 2014 Feb; 13(1):77-86. PubMed ID: 23862748
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CIP2A attenuates tumor progression by inducing cell cycle arrest and promoting cellular senescence in hepatocellular carcinoma.
Yang X; Qu K; Tao J; Yin G; Han S; Liu Q; Sun H
Biochem Biophys Res Commun; 2018 Jan; 495(2):1807-1814. PubMed ID: 29175329
[TBL] [Abstract][Full Text] [Related]
14. Liver-specific gene therapy of hepatocellular carcinoma by targeting human telomerase reverse transcriptase with pegylated immuno-lipopolyplexes.
Hu Y; Shen Y; Ji B; Yin S; Ren X; Chen T; Ma Y; Zhang Z; Zhang Y
Eur J Pharm Biopharm; 2011 Aug; 78(3):320-5. PubMed ID: 21220007
[TBL] [Abstract][Full Text] [Related]
15. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas.
Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW
Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143
[TBL] [Abstract][Full Text] [Related]
16. HCV core inhibits hepatocellular carcinoma cell replicative senescence through downregulating microRNA-138 expression.
Shiu TY; Shih YL; Feng AC; Lin HH; Huang SM; Huang TY; Hsieh CB; Chang WK; Hsieh TY
J Mol Med (Berl); 2017 Jun; 95(6):629-639. PubMed ID: 28258280
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological significance of miR-149 and PARP-2 in hepatocellular carcinoma and their roles in chemo/radiotherapy.
Lin L; Zhang YD; Chen ZY; Chen Y; Ren CP
Tumour Biol; 2016 Sep; 37(9):12339-12346. PubMed ID: 27300349
[TBL] [Abstract][Full Text] [Related]
18. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
19. 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop.
Xia C; Shui L; Lou G; Ye B; Zhu W; Wang J; Wu S; Xu X; Mao L; Xu W; Chen Z; Liu Y; Zheng M
Sci Rep; 2017 Jun; 7(1):4396. PubMed ID: 28667294
[TBL] [Abstract][Full Text] [Related]
20. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.
Pu H; Zheng Q; Li H; Wu M; An J; Gui X; Li T; Lu D
Oncotarget; 2015 Dec; 6(38):40775-98. PubMed ID: 26513297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
